ALRN logo

Aileron Therapeutics (ALRN)

Profile

Full Name

Rein Therapeutics Inc.

Ticker Symbol

ALRN

Exchange

NASDAQ

Sector

Healthcare

Industry

Biotechnology

Country

United States

IPO

June 29, 2017

Indexes

Not included

Website

http://www.aileronrx.com

Employees

15

Key Details

Price

-

Market cap

-

Last Dividend

-

TTM Dividend yield

-

Annual revenue

-

Annual EPS

-$3.42(+43.19% YoY)

PE ratio

-

Next earnings date

N/A

Next ex-dividend date

N/A

Next split date

N/A

Price

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Current Price

-
ALRN price value is unknown

30-Day Relative Volume

-
ALRN 30-day relative volume value is unknown

Price Performance

Price Most recent change

-
ALRN price change on Jan 1, 1 is unknown

Price YTD change

-
ALRN price ytd change is unknown

Price 1-year change

-
ALRN price 1-year change is unknown

Price 3-year change

-
ALRN price 3-year change is unknown

Price Range

Price All-time high

$309.60
ALRN price is currently at an all-time high

Price 3-year low

$1.01
ALRN price is currently at its 3-year low

Capitalization

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Market cap

Market cap

-
ALRN market capitalization value is unknown

Market cap 3-year change

-
ALRN market capitalization 3-year change is unknown

Market cap All-time high

$219.45M
ALRN market capitalization is currently at an all-time high

Market cap sector rank

-
ALRN market capitalization is unknown

Shares Outstanding

Shares Outstanding 1-Year Change

+27.65%
ALRN shares outstanding is up +27.65% year-on-year

Shares Outstanding 3-Year Change

+377.1%
ALRN shares outstanding is up +377.1% over the past 3 years

Technical Indicators

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Beta

-
ALRN beta value is unknown

200-day SMA

-
ALRN SMA 200 is unknown

50-day SMA

-
ALRN SMA 50 is unknown

RSI

-
ALRN 14-day relative strength index value is unknown

Volume

-
ALRN 30-day relative volume value is unknown

ATR

-
ALRN average true range value is unknown

10-day Historical Volatility

-
ALRN 10-day historical volatility value is unknown

Dividend

Income Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Revenue

Revenue

-
ALRN annual revenue value is unknown

Revenue Analysts estimate

-
ALRN annual revenue consensus analysts' forecast is unknown

Revenue 1-year change

-
ALRN annual revenue 1-year change is unknown

Revenue Sector rank

-
ALRN annual revenue is unknown

EPS

EPS

-$3.42
ALRN annual earnings per share is -$3.42

EPS Analysts estimate

-$2.24
ALRN annual earnings per share is currently +52.68% higher than the consensus analysts' forecast

EPS 1-year change

+43.19%
ALRN annual earnings per share is up +43.19% year-on-year

EPS Sector rank

-
ALRN annual earnings per share is unknown

Profit

Gross profit

-
ALRN annual gross profit value is unknown

Gross margin

-
ALRN annual gross profit margin value is unknown

Operating profit

-$15.35M
ALRN annual operating income is -$15.35 million

Operating margin

-
ALRN annual operating profit margin value is unknown

Net income

-$15.73M
ALRN annual net profit is -$15.73 million

Net margin

-
ALRN annual net profit margin value is unknown

Expenses

Total expenses

$15.35M
ALRN annual total expenses is $15.35 million

Operating expenses

$15.35M
ALRN annual total operating expenses is $15.35 million

Cost of goods sold

-
ALRN annual cost of goods sold value is unknown

Selling, general & administrative expenses

$11.36M
ALRN annual SGA is $11.36 million

Depreciation and amortization

$119.00K
ALRN annual depreciation & amortization is $119.00 thousand

Interest expense

-
ALRN annual interest expense value is unknown

Income tax

-
ALRN annual income tax value is unknown

EBIT & EBITDA

EBIT

-$15.35M
ALRN annual earnings before interest & taxes is -$15.35 million

EBITDA

-$15.23M
ALRN annual EBITDA is -$15.23 million

Balance Sheet

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Assets

Total assets

$106.01M
ALRN annual total assets is $106.01 million

Non current assets

$87.74M
ALRN annual long term assets is $87.74 million

Current assets

$18.27M
ALRN annual total current assets is $18.27 million

Cash and cash equivalents

$17.31M
ALRN annual cash & cash equivalents is $17.31 million

Accounts receivable

-
ALRN annual accounts receivable value is unknown

Inventory

-
ALRN annual inventory value is unknown

Liabilities

Total liabilities

$99.12M
ALRN annual total liabilities is $99.12 million

Long term liabilities

$94.74M
ALRN annual total long term liabilities is $94.74 million

Current liabilities

$4.38M
ALRN annual total current liabilities is $4.38 million

Accounts payable

$1.19M
ALRN annual accounts payable is $1.19 million

Debt

Total debt

$48.00K
ALRN annual total debt is $48.00 thousand

Total debt 1-year change

+45.45%
ALRN annual total debt is up +45.45% year-on-year

Long term debt

-
ALRN annual long term debt value is unknown

Short term debt

$48.00K
ALRN annual short term debt is $48.00 thousand

Equity & Capital

Shareholders equity

$6.89M
ALRN annual stockholders equity is $6.89 million

Book value

$6.89M
ALRN annual book value is $6.89 million

Retained earnings

-$288.52M
ALRN annual retained earnings is -$288.52 million

Working capital

$13.88M
ALRN annual working capital is $13.88 million

Cash Flow Statement

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Cashflow Activities

Cash from operations

-$19.81M
ALRN annual cash flow from operations is -$19.81 million

Cash from operations 1-year change

+20.34%
ALRN annual cash flow from operations is up +20.34% year-on-year

Cash from investing

$16.20M
ALRN annual cash flow from investing activities is $16.20 million

Cash from investing 1-year change

-38.79%
ALRN annual cash flow from investing activities is down -38.79% year-on-year

Cash from financing

$15.79M
ALRN annual cash flow from financing activities is $15.79 million

Cash from financing 1-year change

+100%
ALRN annual cash flow from financing activities is up +100% year-on-year

CAPEX

CAPEX

-
ALRN annual capital expenditures value is unknown

CAPEX 1-year change

-
ALRN annual capital expenditures 1-year change is unknown

Free Cash Flow

Free cash flow

-$19.81M
ALRN annual free cash flow is -$19.81 million

Free cash flow 1-year change

+20.34%
ALRN annual free cash flow is up +20.34% year-on-year

Profitability Ratios

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Margins

Gross margin

-
ALRN annual gross profit margin value is unknown

Operating margin

-
ALRN annual operating profit margin value is unknown

Net margin

-
ALRN annual net profit margin value is unknown

ROA & ROE

ROA

-14.84%
ALRN annual return on assets is -14.84%

ROE

-228.43%
ALRN annual return on equity is -228.43%

Valuation

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

PE Ratio

PE ratio

-
ALRN price to earnings ratio value is unknown

PE ratio Sector rank

-
ALRN price to earnings ratio is unknown

PB Ratio

PB ratio

-
ALRN price to book ratio value is unknown

PB ratio Sector rank

-
ALRN price to book ratio is unknown

PS Ratio

PS ratio

-
ALRN price to sales ratio value is unknown

PS ratio Sector rank

-
ALRN price to sales ratio is unknown

Enterprise value

Enterprise value

-
ALRN enterprise value value is unknown

Enterprise value Sector rank

-
ALRN enterprise value is unknown

EV/EBITDA

EV/EBITDA

-
ALRN EV/EBITDA value is unknown

EV/EBITDA Sector rank

-
ALRN EV/EBITDA is unknown

Financial Health

Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Liquidity

Current ratio

4.17
ALRN annual current ratio is 4.17

Quick ratio

-
ALRN annual quick ratio value is unknown

Leverage

Debt to equity

0.01
ALRN annual debt to equity ratio is 0.01

Interest coverage ratio

-
ALRN annual interest coverage ratio value is unknown

Risk & Stability

Piotroski F-Score

-
ALRN piotroski f-score value is unknown

Altman Z-Score

-
ALRN altman z-score value is unknown

Analyst ratings

Recent major analysts updates

Apr 18, 24 Ladenburg Thalmann
Buy
Dec 1, 23 Ladenburg Thalmann
Buy
Jun 30, 22 HC Wainwright & Co.
Buy
Jun 29, 22 William Blair
Market Perform
Jun 5, 20 HC Wainwright & Co.
Buy
Mar 31, 20 H.C. Wainwright
Buy
Apr 9, 19 Canaccord Genuity
Buy
Mar 11, 19 H.C. Wainwright
Buy
Jul 24, 17 Jefferies
Buy
Jul 24, 17 Canaccord Genuity
Buy

Institutional Ownership

Similar stocks

  • What is the ticker symbol for Aileron Therapeutics?
  • Does Aileron Therapeutics pay dividends?
  • What sector is Aileron Therapeutics in?
  • What industry is Aileron Therapeutics in?
  • What country is Aileron Therapeutics based in?
  • When did Aileron Therapeutics go public?
  • Is Aileron Therapeutics in the S&P 500?
  • Is Aileron Therapeutics in the NASDAQ 100?
  • Is Aileron Therapeutics in the Dow Jones?
  • When was Aileron Therapeutics's last earnings report?
  • When does Aileron Therapeutics report earnings?
  • Should I buy Aileron Therapeutics stock now?

What is the ticker symbol for Aileron Therapeutics?

The ticker symbol for Aileron Therapeutics is NASDAQ:ALRN

Does Aileron Therapeutics pay dividends?

No, Aileron Therapeutics does not pay dividends

What sector is Aileron Therapeutics in?

Aileron Therapeutics is in the Healthcare sector

What industry is Aileron Therapeutics in?

Aileron Therapeutics is in the Biotechnology industry

What country is Aileron Therapeutics based in?

Aileron Therapeutics is headquartered in United States

When did Aileron Therapeutics go public?

Aileron Therapeutics's initial public offering (IPO) was on June 29, 2017

Is Aileron Therapeutics in the S&P 500?

No, Aileron Therapeutics is not included in the S&P 500 index

Is Aileron Therapeutics in the NASDAQ 100?

No, Aileron Therapeutics is not included in the NASDAQ 100 index

Is Aileron Therapeutics in the Dow Jones?

No, Aileron Therapeutics is not included in the Dow Jones index

When was Aileron Therapeutics's last earnings report?

Aileron Therapeutics's most recent earnings report was on Apr 15, 2025

When does Aileron Therapeutics report earnings?

The date for Aileron Therapeutics's next earnings report has not been announced yet

Should I buy Aileron Therapeutics stock now?

As of today, analysts generally recommend a 'Strong buy' rating. However, it's important to do your own research and consider your financial situation before making any investment decisions
On this page